Home / World Marketplace / Archive by category Global Health & Biotech (Page 68)

Archive by category Global Health & Biotech

Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest Clinical Trial Data

BOSTON, June 21, 2024 (Korea Bizwire) – Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has today released a key research whitepaper entitled Antibody-drug conjugates – Global Clinical Trial Landscape. Novotech’s whitepaper examines how the antibody-drug conjugates (ADCs), [...]

Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform

Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging or previously undruggable disease targets Financing led by 3E Bioventures Capital and Proxima Ventures Ltd. with participation from Lapam Capital Founded by Professor Jun O. Liu of Johns Hopkins University School of Medicine, a pioneer in the molecular [...]

Philips Completes Cancellation of 4.4 Million Shares

June 19, 2024, Amsterdam, the Netherlands (Korea Bizwire) – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021. Philips’ current issued [...]

Future Health Index 2024 Global Report: Healthcare Leaders Turn to AI to Address Critical Gaps in Patient Care

Healthcare leaders indicate automation is crucial in addressing staff shortages, but staff remain skeptical Interest in Generative AI grows, with majority of health leaders investing in, or planning to invest in AI technologies to help reduce delays in patient care June 18, 2024, Amsterdam, the Netherlands (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global [...]

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Small Cell Lung Cancer

SHANGHAI, June 18, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for toripalimab (product code: JS001) in [...]

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers

VANCOUVER, British Columbia, June 17, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for ZW171, [...]

ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)

A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer. Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic cancer, measured in patients’ blood using CA19-9 as biomarker, determines survival chances and can be used as a quick way to assess treatment [...]

From Awareness to Action on Global Fatty Liver Day

Global Liver Institute Unites the Field in Times of Name Changes and New Treatments WASHINGTON, Jun. 13 (Korea Bizwire) — Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores the crucial need for early identification and treatment [...]

Alta Semper Acquires Allmed Group to Deliver Advanced Blood Purification and Dialysis Solutions Worldwide

Alta Semper acquires Allmed Group to deliver advanced blood purification and dialysis solutions worldwide London, UK, 13th of June 2024; Allmed Group (“Allmed” or “the Company“), a producer of end-to-end blood purification and haemodialysis solutions, announced today that Alta Semper Capital (“Alta Semper”), a London-based private equity firm specialising in impact investments primarily in the healthcare sector across [...]

Smith+Nephew Personalizes Robotic-assisted Surgery for Patients and Surgeons with Launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services Exclusively for the CORI™ Surgical System

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its new CORIOGRAPH Pre-Operative Planning and Modeling Services, providing an unparalleled, personalized solution for surgeons and patients across partial and total knee arthroplasty procedures. It is exclusively for use with the CORI Surgical System – the only orthopaedic robotic-assisted system to offer [...]